Skip to main content
. 2017 May 12;51(3):215–222. doi: 10.1016/j.aott.2017.02.001

Table 1.

Quality assessment items and possible scores.

A. Was the assigned treatment adequately concealed prior to allocation?
2 = method did not allow disclosure of assignment
1 = small but possible chance of disclosure of assignment or unclear
0 = quasi-randomised or open list/tables
B. Were the outcomes of participants who withdrew described and included in the analysis (intention to treat)?
2 = withdrawals well described and accounted for in analysis
1 = withdrawals described and analysis not possible
0 = no mention, inadequate mention, or obvious differences and no adjustment
C. Were the outcome assessors blinded to treatment status?
2 = effective action taken to blind assessors
1 = small or moderate chance of unblinding of assessors
0 = not mentioned or not possible
D. Were the treatment and control group comparable at entry? (Likely confounders may be age, partial or total rupture, activity level, acute or chronic injury)
2 = good comparability of groups, or confounding adjusted for in analysis
1 = confounding small; mentioned but not adjusted for
0 = large potential for confounding, or not discussed
E. Were the participants blind to assignment status after allocation?
2 = effective action taken to blind participants
1 = small or moderate chance of unblinding of participants
0 = not possible, or not mentioned (unless double-blind), or possible but not done
F. Were the treatment providers blind to assignment status?
2 = effective action taken to blind treatment providers
1 = small or moderate chance of unblinding of treatment providers
0 = not possible, or not mentioned (unless double-blind), or possible but not done
G. Were care programmes, other than the trial options, identical?
2 = care programmes clearly identical
1 = clear but trivial differences
0 = not mentioned or clear and important differences in care programmes
H. Were the inclusion and exclusion criteria clearly defined?
2 = clearly defined
1 = inadequately defined
0 = not defined
I. Were the interventions clearly defined?
2 = clearly defined interventions are applied with a standardised protocol
1 = clearly defined interventions are applied but the application protocol is not standardised
0 = intervention and/or application protocol are poorly or not defined
J. Were the outcome measures used clearly defined? (by outcome)
2 = clearly defined
1 = inadequately defined
0 = not defined
K. Were diagnostic tests used in outcome assessment clinically useful? (by outcome)
2 = optimal
1 = adequate
0 = not defined, not adequate
L. Was the surveillance active, and of clinically appropriate duration?
2 = active surveillance and appropriate duration
1 = active surveillance, but inadequate duration
0 = surveillance not active or not defined